You can find the annual or quarterly income statement of Aspire Biopharma Holdings Inc here for insights into the performance and operational efficiency of Aspire Biopharma Holdings Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q3

FY2021Q2

FY2021Q1

Total revenue

--1.94K

----

Revenue

--1.94K

----

Cost of revenue

--1.06K

----

Operating expenses

81.91%1.15M

59.65%799.89K

516.67%15.56M

-240.53%-565.79K

94.24%630.77K

73.81%501.01K

677.25%2.52M

28.21%402.62K

27.22%324.74K

-3.22%288.25K

197.17%324.56K

--314.03K

1567.26%255.26K

12398.53%297.84K

1454.28%109.22K

--15.31K

--2.38K

--7.03K

R&D expenses

--207.90K

--352.89K

--263.09K

----

Depreciation, depletion, and amortization

--0.00

----

--0.00

----

Other operating expenses

---1.06K

----

Operating profit

-81.60%-1.15M

-59.65%-799.89K

-516.67%-15.56M

240.53%565.79K

-94.24%-630.77K

-73.81%-501.01K

-677.25%-2.52M

-28.21%-402.62K

-27.22%-324.74K

3.22%-288.25K

-197.17%-324.56K

---314.03K

-1567.26%-255.26K

-12398.53%-297.84K

-1454.28%-109.22K

---15.31K

---2.38K

---7.03K

Net non-operating interest income (expenses)

Non-operating interest income

----

-74.23%67.17K

-69.96%76.75K

-91.91%169.91K

-92.65%234.85K

-89.75%260.67K

-80.83%255.48K

401.77%2.10M

14844.13%3.20M

--2.54M

--1.33M

--418.53K

--21.39K

----

Non-operating interest expense

--1.48M

--527.89K

58.16%289.93K

9844.50%891.62K

----

--183.31K

--8.97K

----

Special income (expenses)

9222.67%775.06K

-213.91%-653.51K

---94.92K

---8.71M

---8.50K

---208.18K

----

Other non-operating income (expenses)

5978.20%1.55M

----

--33.44K

--25.50K

---62.97K

--4.03K

----

Income before tax

-244.59%-1.85M

-228.98%-1.98M

-546.16%-15.94M

-5818.04%-8.93M

-675.39%-537.02K

-133.24%-602.26K

-185.89%-2.47M

-106.77%-150.91K

-106.43%-69.26K

1401.18%1.81M

3370.60%2.87M

--2.23M

7136.03%1.08M

5164.75%120.69K

-1149.84%-87.83K

---15.31K

---2.38K

---7.03K

Income tax

--0.00

----

Income after tax

-244.59%-1.85M

-228.98%-1.98M

-546.16%-15.94M

-5818.04%-8.93M

-675.39%-537.02K

-133.24%-602.26K

-185.89%-2.47M

-106.77%-150.91K

-106.43%-69.26K

1401.18%1.81M

3370.60%2.87M

--2.23M

7136.03%1.08M

5164.75%120.69K

-1149.84%-87.83K

---15.31K

---2.38K

---7.03K

Net income from continuous operations

-244.59%-1.85M

-228.98%-1.98M

-546.16%-15.94M

-5818.04%-8.93M

-675.39%-537.02K

-133.24%-602.26K

-185.89%-2.47M

-106.77%-150.91K

-106.43%-69.26K

1401.18%1.81M

3370.60%2.87M

--2.23M

7136.03%1.08M

5164.75%120.69K

-1149.84%-87.83K

---15.31K

---2.38K

---7.03K

Net income attributable to controlling interests

-244.59%-1.85M

-228.98%-1.98M

-546.16%-15.94M

-5818.04%-8.93M

-675.39%-537.02K

-133.24%-602.26K

-185.89%-2.47M

-106.77%-150.91K

-106.43%-69.26K

1401.18%1.81M

3370.60%2.87M

--2.23M

7136.03%1.08M

5164.75%120.69K

-1149.84%-87.83K

---15.31K

---2.38K

---7.03K

Net income attributable to common shareholders

-244.59%-1.85M

-228.98%-1.98M

-546.16%-15.94M

-5818.04%-8.93M

-675.39%-537.02K

-133.24%-602.26K

-185.89%-2.47M

-106.77%-150.91K

-106.43%-69.26K

1401.18%1.81M

3370.60%2.87M

--2.23M

7136.03%1.08M

5164.75%120.69K

-1149.84%-87.83K

---15.31K

---2.38K

---7.03K

Basic earnings per share

45.98%-0.04

43.55%-0.04

-53.33%-0.42

-6668.65%-1.15

-798.18%-0.07

-177.07%-0.07

-443.29%-0.27

-127.43%-0.02

-125.69%-0.01

2647.02%0.09

1800.64%0.08

--0.06

5650.00%0.03

4300.00%0.00

-1780.00%0.00

--0.00

Diluted earnings per share

45.98%-0.04

43.55%-0.04

-53.33%-0.42

-6668.65%-1.15

-798.18%-0.07

-177.07%-0.07

-443.29%-0.27

-127.43%-0.02

-125.69%-0.01

2647.02%0.09

1800.64%0.08

--0.06

5650.00%0.03

4300.00%0.00

-1780.00%0.00

--0.00

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

